Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

The Use of Fluorescence Imaging in Colon Interposition for Esophageal Replacement: A Technical Note.

Wiesel O, Shaw JP, Ramjist J, Brichkov I, Sherwinter DA.

J Laparoendosc Adv Surg Tech A. 2019 Jun 5. doi: 10.1089/lap.2019.0244. [Epub ahead of print]

PMID:
31166832
2.

Multiseed liposomal drug delivery system using micelle gradient as driving force to improve amphiphilic drug retention and its anti-tumor efficacy.

Zhang W, Li C, Jin Y, Liu X, Wang Z, Shaw JP, Baguley BC, Wu Z, Liu J.

Drug Deliv. 2018 Nov;25(1):611-622. doi: 10.1080/10717544.2018.1440669.

3.

Optimization of Weight Ratio for DSPE-PEG/TPGS Hybrid Micelles to Improve Drug Retention and Tumor Penetration.

Jin Y, Wu Z, Li C, Zhou W, Shaw JP, Baguley BC, Liu J, Zhang W.

Pharm Res. 2018 Jan 4;35(1):13. doi: 10.1007/s11095-017-2340-y.

PMID:
29302821
4.

Simultaneous unilateral anterior thoracoscopy with transcervical thyroidectomy for the resection of large mediastinal thyroid goiter.

Brichkov I, Chiba S, Lagmay V, Shaw JP, Harris LJ, Weiss M.

J Thorac Dis. 2017 Aug;9(8):2484-2490. doi: 10.21037/jtd.2017.07.89.

5.

Optimization of the formation of embedded multicellular spheroids of MCF-7 cells: How to reliably produce a biomimetic 3D model.

Zhang W, Li C, Baguley BC, Zhou F, Zhou W, Shaw JP, Wang Z, Wu Z, Liu J.

Anal Biochem. 2016 Dec 15;515:47-54. doi: 10.1016/j.ab.2016.10.004. Epub 2016 Oct 5.

PMID:
27717854
6.

Improving drug retention in liposomes by aging with the aid of glucose.

Zhang W, Falconer JR, Baguley BC, Shaw JP, Kanamala M, Xu H, Wang G, Liu J, Wu Z.

Int J Pharm. 2016 May 30;505(1-2):194-203. doi: 10.1016/j.ijpharm.2016.03.044. Epub 2016 Mar 25.

PMID:
27021465
7.

Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand.

Shaw JP, Gauld N, Kelly F.

Int J Pharm Pract. 2016 Feb;24(1):6-12. doi: 10.1111/ijpp.12200. Epub 2015 Jul 7.

PMID:
26154432
8.

Anti-oxidative cellular protection effect of fasting-induced autophagy as a mechanism for hormesis.

Moore MN, Shaw JP, Ferrar Adams DR, Viarengo A.

Mar Environ Res. 2015 Jun;107:35-44. doi: 10.1016/j.marenvres.2015.04.001. Epub 2015 Apr 8.

PMID:
25881010
9.

Post-insertion of poloxamer 188 strengthened liposomal membrane and reduced drug irritancy and in vivo precipitation, superior to PEGylation.

Zhang W, Wang G, See E, Shaw JP, Baguley BC, Liu J, Amirapu S, Wu Z.

J Control Release. 2015 Apr 10;203:161-9. doi: 10.1016/j.jconrel.2015.02.026. Epub 2015 Feb 19.

PMID:
25701612
10.

Complete Genome of Citrobacter freundii Siphophage Stevie.

Shaw JP, Aviles Medina CA, Chen Y, Luna AJ, Hernandez AC, Kuty Everett GF.

Genome Announc. 2015 Feb 5;3(1). pii: e01434-14. doi: 10.1128/genomeA.01434-14.

11.

Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer drug.

Zhang W, Wang G, Falconer JR, Baguley BC, Shaw JP, Liu J, Xu H, See E, Sun J, Aa J, Wu Z.

Pharm Res. 2015 Apr;32(4):1451-61. doi: 10.1007/s11095-014-1551-8. Epub 2014 Oct 30.

PMID:
25355460
12.

Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care.

Harrison J, Shaw JP, Harrison JE.

Int J Pharm Pract. 2015 Jun;23(3):173-81. doi: 10.1111/ijpp.12148. Epub 2014 Sep 23.

PMID:
25250655
13.

Physicochemical characterization of asulacrine towards the development of an anticancer liposomal formulation via active drug loading: stability, solubility, lipophilicity and ionization.

See E, Zhang W, Liu J, Svirskis D, Baguley BC, Shaw JP, Wang G, Wu Z.

Int J Pharm. 2014 Oct 1;473(1-2):528-35. doi: 10.1016/j.ijpharm.2014.07.033. Epub 2014 Jul 28.

PMID:
25079434
14.

In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems.

Wu Z, Hassan D, Shaw JP.

J Pharm Pharmacol. 2013 Oct;65(10):1429-39. doi: 10.1111/jphp.12114. Epub 2013 Jul 24. Review.

PMID:
24028610
15.

Subdiaphragmatic bronchogenic cyst at the gastroesophageal junction presenting with Dysphagia: a case report.

Ballehaninna UK, Shaw JP, Brichkov I.

Surg Laparosc Endosc Percutan Tech. 2013 Aug;23(4):e170-2. doi: 10.1097/SLE.0b013e31828e3e54.

PMID:
23917610
16.

Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.

McKinnell RM, Armstrong SR, Beattie DT, Fatheree PR, Long DD, Marquess DG, Shaw JP, Vickery RG.

Bioorg Med Chem Lett. 2013 Jul 15;23(14):4210-5. doi: 10.1016/j.bmcl.2013.05.018. Epub 2013 May 16.

PMID:
23756062
17.

Traction esophageal diverticulum: a rare cause of gastro-intestinal bleeding.

Ballehaninna UK, Shaw JP, Brichkov I.

Springerplus. 2012 Nov 21;1(1):50. doi: 10.1186/2193-1801-1-50. Print 2012 Dec.

18.

A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist/carbonic anhydrase-II inhibitors for the treatment of glaucoma.

Long DD, Frieman B, Hegde SS, Hill CM, Jiang L, Kintz S, Marquess DG, Purkey H, Shaw JP, Steinfeld T, Wilson MS, Wrench K.

Bioorg Med Chem Lett. 2013 Feb 15;23(4):939-43. doi: 10.1016/j.bmcl.2012.12.058. Epub 2012 Dec 22.

PMID:
23317571
19.

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.

Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Genov D, Goldblum AA, Humphrey PP, Jiang L, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6048-52. doi: 10.1016/j.bmcl.2012.08.051. Epub 2012 Aug 21.

PMID:
22959244
20.

Surgery for other pulmonary fungal infections, Actinomyces, and Nocardia.

LoCicero J 3rd, Shaw JP, Lazzaro RS.

Thorac Surg Clin. 2012 Aug;22(3):363-74. doi: 10.1016/j.thorsurg.2012.04.002. Review.

PMID:
22789599
21.

Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.

Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum AA, Humphrey PP, Marquess DG, Shaw JP, Smith JA, Derek Turner S, Vickery RG.

Bioorg Med Chem Lett. 2012 Jul 15;22(14):4849-53. doi: 10.1016/j.bmcl.2012.05.034. Epub 2012 May 15.

PMID:
22683222
22.

Population pharmacokinetics of telavancin in healthy subjects and patients with infections.

Samara E, Shaw JP, Barriere SL, Wong SL, Worboys P.

Antimicrob Agents Chemother. 2012 Apr;56(4):2067-73. doi: 10.1128/AAC.05915-11. Epub 2012 Jan 17.

23.

Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.

Hegde SS, Okusanya OO, Skinner R, Shaw JP, Obedencio G, Ambrose PG, Blais J, Bhavnani SM.

Antimicrob Agents Chemother. 2012 Mar;56(3):1578-83. doi: 10.1128/AAC.05382-11. Epub 2011 Dec 12.

24.

Pneumothorax in a young man in Brooklyn, New York.

Tiu CT, Cook J, Pineros DF, Rankin LF, Lin YS, Ghitan M, Brichkov I, Shaw JP, Chapnick EK.

Clin Infect Dis. 2011 Dec;53(12):1255, 1296-7. doi: 10.1093/cid/cir640. No abstract available.

PMID:
22080120
25.

Preparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cells.

Gu X, Zhang W, Liu J, Shaw JP, Shen Y, Xu Y, Lu H, Wu Z.

AAPS PharmSciTech. 2011 Dec;12(4):1200-8. doi: 10.1208/s12249-011-9668-0. Epub 2011 Sep 17.

26.

Differential response of the homoploid hybrid species Iris nelsonii (Iridaceae) and its progenitors to abiotic habitat conditions.

Taylor SJ, Willard RW, Shaw JP, Dobson MC, Martin NH.

Am J Bot. 2011 Aug;98(8):1309-16. doi: 10.3732/ajb.1100012.

27.

Integration of biochemical, histochemical and toxicogenomic indices for the assessment of health status of mussels from the Tamar Estuary, U.K.

Shaw JP, Dondero F, Moore MN, Negri A, Dagnino A, Readman JW, Lowe DR, Frickers PE, Beesley A, Thain JE, Viarengo A.

Mar Environ Res. 2011 Jul;72(1-2):13-24. doi: 10.1016/j.marenvres.2011.05.003. Epub 2011 May 30.

PMID:
21683998
28.

Introduction to the Department for Environment, Food and Rural Affairs (Defra) PREDICT 2 Tamar Estuary Research Workshop: pathological risk evaluation using "health status-related" biomarkers.

Shaw JP, Moore MN.

Mar Environ Res. 2011 Jul;72(1-2):1-2. doi: 10.1016/j.marenvres.2011.05.002. Epub 2011 May 30. No abstract available.

PMID:
21683997
29.

Synthesis and pharmacokinetics of strontium fructose 1,6-diphosphate (Sr-FDP) as a potential anti-osteoporosis agent in intact and ovariectomized rats.

Ma B, Zhang Q, Wang G, Wu Z, Shaw JP, Hu Y, Wang Y, Zheng Y, Yang Z, Ying H.

J Inorg Biochem. 2011 Apr;105(4):563-8. doi: 10.1016/j.jinorgbio.2011.01.001. Epub 2011 Jan 11.

PMID:
21345324
30.

Identification of a putative regulator of early T cell activation genes. Science. 1988. 241: 202-205.

Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA, Crabtree GR.

J Immunol. 2010 Nov 1;185(9):4972-5. No abstract available.

31.

An interspecies extrapolation of the pharmacokinetics of telavancin, a rapidly bactericidal, concentration-dependent antibiotic.

Shaw JP, Jaw-Tsai S.

Xenobiotica. 2011 Jan;41(1):82-9. doi: 10.3109/00498254.2010.525261. Epub 2010 Oct 15.

PMID:
20946087
32.

Single-dose pharmacokinetics and tolerability of telavancin in elderly men and women.

Goldberg MR, Wong SL, Shaw JP, Kitt MM, Barriere SL.

Pharmacotherapy. 2010 Aug;30(8):806-11. doi: 10.1592/phco.30.8.806.

PMID:
20653356
33.

Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteers.

Shaw JP, Cheong J, Goldberg MR, Kitt MM.

Antimicrob Agents Chemother. 2010 Aug;54(8):3365-71. doi: 10.1128/AAC.01750-09. Epub 2010 Jun 1.

34.

The p110delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.

Berndt A, Miller S, Williams O, Le DD, Houseman BT, Pacold JI, Gorrec F, Hon WC, Liu Y, Rommel C, Gaillard P, Rückle T, Schwarz MK, Shokat KM, Shaw JP, Williams RL.

Nat Chem Biol. 2010 Mar;6(3):244. No abstract available.

PMID:
20154668
35.

The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors.

Berndt A, Miller S, Williams O, Le DD, Houseman BT, Pacold JI, Gorrec F, Hon WC, Liu Y, Rommel C, Gaillard P, Rückle T, Schwarz MK, Shokat KM, Shaw JP, Williams RL.

Nat Chem Biol. 2010 Feb;6(2):117-24. doi: 10.1038/nchembio.293.

36.

Thoracic surgery in the elderly: areas of future research and studies.

LoCicero J 3rd, Shaw JP.

Thorac Surg Clin. 2009 Aug;19(3):409-13, vii. doi: 10.1016/j.thorsurg.2009.07.003. Review.

PMID:
20066952
37.

Structural basis of chemokine sequestration by a tick chemokine binding protein: the crystal structure of the complex between Evasin-1 and CCL3.

Dias JM, Losberger C, Déruaz M, Power CA, Proudfoot AE, Shaw JP.

PLoS One. 2009 Dec 30;4(12):e8514. doi: 10.1371/journal.pone.0008514.

38.

Lack of effect of moderate hepatic impairment on the pharmacokinetics of telavancin.

Goldberg MR, Wong SL, Shaw JP, Kitt MM, Barriere SL.

Pharmacotherapy. 2010 Jan;30(1):35-42. doi: 10.1592/phco.30.1.35.

PMID:
20030471
39.

Effects on feeding rate and biomarker responses of marine mussels experimentally exposed to propranolol and acetaminophen.

Solé M, Shaw JP, Frickers PE, Readman JW, Hutchinson TH.

Anal Bioanal Chem. 2010 Jan;396(2):649-56. doi: 10.1007/s00216-009-3182-1. Epub 2009 Oct 18.

PMID:
19838684
40.

A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.

McKinnell RM, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum A, Humphrey PP, Long DD, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG.

J Med Chem. 2009 Sep 10;52(17):5330-43. doi: 10.1021/jm900881j.

PMID:
19663444
41.

Identification and characterization of novel small molecules as potent inhibitors of the plasmodial calcium-dependent protein kinase 1.

Lemercier G, Fernandez-Montalvan A, Shaw JP, Kugelstadt D, Bomke J, Domostoj M, Schwarz MK, Scheer A, Kappes B, Leroy D.

Biochemistry. 2009 Jul 14;48(27):6379-89. doi: 10.1021/bi9005122.

PMID:
19507895
42.

Extending the environmental risk assessment for oseltamivir (Tamiflu) under pandemic use conditions to the coastal marine compartment.

Hutchinson TH, Beesley A, Frickers PE, Readman JW, Shaw JP, Straub JO.

Environ Int. 2009 Aug;35(6):931-6. doi: 10.1016/j.envint.2009.04.001. Epub 2009 Apr 23.

PMID:
19395032
43.

Surveillance of a recently switched non-prescription medicine (Diclofenac) using a pharmacy-based approach.

Gauld NJ, Shaw JP, Emmerton LM, Pethica BD.

Pharmacoepidemiol Drug Saf. 2000 May;9(3):207-14. doi: 10.1002/1099-1557(200005/06)9:3<207::AID-PDS483>3.0.CO;2-S.

PMID:
19025821
44.

Ticks produce highly selective chemokine binding proteins with antiinflammatory activity.

Déruaz M, Frauenschuh A, Alessandri AL, Dias JM, Coelho FM, Russo RC, Ferreira BR, Graham GJ, Shaw JP, Wells TN, Teixeira MM, Power CA, Proudfoot AE.

J Exp Med. 2008 Sep 1;205(9):2019-31. doi: 10.1084/jem.20072689. Epub 2008 Aug 4.

45.

The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Smith JA, Beattie DT, Marquess D, Shaw JP, Vickery RG, Humphrey PP.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):125-37. doi: 10.1007/s00210-008-0282-y. Epub 2008 Apr 16.

PMID:
18415081
46.

The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.

Beattie DT, Armstrong SR, Shaw JP, Marquess D, Sandlund C, Smith JA, Taylor JA, Humphrey PP.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Jul;378(1):139-47. doi: 10.1007/s00210-008-0281-z. Epub 2008 Apr 12.

PMID:
18408918
47.

Pseudocavitating bronchioloalveolar carcinoma followed over a decade.

Shaw JP, Bejarano PA, Thurer RJ.

Ann Thorac Surg. 2008 Apr;85(4):1432-4. doi: 10.1016/j.athoracsur.2007.10.031.

PMID:
18355545
48.

Video-assisted thoracoscopic lobectomy: state of the art and future directions.

Shaw JP, Dembitzer FR, Wisnivesky JP, Litle VR, Weiser TS, Yun J, Chin C, Swanson SJ.

Ann Thorac Surg. 2008 Feb;85(2):S705-9. doi: 10.1016/j.athoracsur.2007.11.048. Review.

PMID:
18222201
49.

Assessing the responsiveness of the Asthma Quality of Life Questionnaire with pharmaceutical care.

Kheir NM, Emmerton L, Shaw JP.

Pharm World Sci. 2008 Aug;30(4):322-8. Epub 2007 Nov 16.

PMID:
18008177
50.

Intrapulmonary distribution of intravenous telavancin in healthy subjects and effect of pulmonary surfactant on in vitro activities of telavancin and other antibiotics.

Gotfried MH, Shaw JP, Benton BM, Krause KM, Goldberg MR, Kitt MM, Barriere SL.

Antimicrob Agents Chemother. 2008 Jan;52(1):92-7. Epub 2007 Oct 8.

Supplemental Content

Support Center